JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2014, Vol. 52 ›› Issue (7): 11-15.doi: 10.6040/j.issn.1671-7554.0.2014.010

Previous Articles     Next Articles

Effect of donepezil on hypothalamic-pituitary-adrenocortical-axis in Alzheimer’s disease rats

WANG Jinhong1, LI Wentao2, YU Shutian1, DONG Li1   

  1. 1. Department of Pharmacology, Weifang Medical University, Weifang 261053, Shandong, China;
    2. Department of Functional Laboratory, Weifang Medical University, Weifang 261053, Shandong, China
  • Received:2014-01-06 Revised:2014-06-10 Online:2014-07-10 Published:2014-07-10

PDF (PC)

342

Abstract: Objective To investigate the effect of donepezil on hypothalamic-pituitary-adrenocortical-axis(HPA)in Alzheimer's disease (AD) rats. Methods A total of 30 healthy male Wistar rats were injected into amyloid β-protein 25-35 (Aβ25-35) intracerebroventricularly and D-galactose (D-gal) intraperitoneally to prepare AD model and divided into normal control group, AD model group, and donepezil group randomly, and 10 rats in each group. Serum hydrocortisone (HYD) and adrenocorticotropic hormone (ACTH) concentrations were detected by radioimmunoassay. Morphology of hypothalamus was observed with transmission electron microscope, and the expressions of corticotropin releasing hormone (CRH) and CRH receptor 1 (CRHR1) were observed by immunohistochemical method. Results Compared with normal control group, learning ability of model rats decreased (P<0.05), HYD concentration increased (P<0.01), ACTH concentration decreased significantly (P<0.01), and the expressions of CRH and CRHR1 reduced. The ultrastructure of hypothalamus of model rats were damaged. Compared with AD model group, donepezil decreased serum concentration of HYD and increased serum concentration of ACTH in the AD rats (P<0.05 or P<0.01 respectively), and improved the expressions of CRH and CRHR1, which protected ultrastructure damage of hypothalamus. Conclusion Donepezil improves the function of HPA in AD rats and shows treatment effect on AD.

Key words: Donepezil, Adrenocorticotropic hormone, Alzheimer’s disease rats, Corticotropin releasing hormone, Hydrocortisone

CLC Number: 

  • R574
[1] Cutuli D, De Bartolo P, Caporali P, et al. Neuroprotective effects of donepezil against cholinergic depletion[J]. Alzheimers Res Ther, 2013, 5(5): 50. doi: 10.1186/alzrt215.
[2] Thakurathi N, Vincenzi B, Henderson D C. Assessing the prospect of donepezil in improving cognitive impairment in patients with schizophrenia[J]. Expert Opin Investig Drugs, 2013, 22(2): 259-265.
[3] Zivin M, Pregelj P. Prolonged treatment with donepezil increases acetylcholinesterase expression in the central nervous system[J]. Psychiatr Danub, 2008, 20(2): 168-173.
[4] Umegaki H, Yamamoto A, Suzuki Y, et al. Responses of hypothalamo-pituitary-adrenal axis to a cholinesterase inhibitor[J]. Neuroreport, 2009, 20 (15): 1366-1370.
[5] Notarianni E. Hypercortisolemia and glucocorticoid receptor-signaling insufficiency in Alzheimer's disease initiation and development[J]. Curr Alzheimer Res, 2013, 10(7): 714-731.
[6] Brureau A, Zussy C, Delair B, et al. Deregulation of hypothalamic-pituitary-adrenal axis functions in an Alzheimer's disease rat model[J]. Neurobiol Aging, 2013, 34(5): 1426-1439.
[7] Xue H Y, Lu Y N, Fang X M, et al. Neuroprotective properties of aucubin in diabetic rats and diabetic encephalopathy rats[J]. Mol Biol Rep, 2012, 39(10): 9311-9318.
[8] 汪润,赵丽娟,王全英,等.β淀粉样蛋白1-42与D-半乳糖联合作用建立复合阿尔茨海默病样模型[J]. 解剖学报, 2011, 42(4): 342-343.
[9] 包新民, 舒斯云. 大鼠脑立体定位图谱[M].2版.北京:人民卫生出版社, 2005: 165.
[10] Mehta S, Chandersekhar K, Prasadrao G, et al. Safety and efficacy of donepezil hydrochloride in patients with mild to moderate Alzheimer's disease: findings of an observational study[J]. Indian J Psychiatry, 2012, 54(4): 337-343.
[11] Sozio P, Cerasa L S, Marinelli L, et al. Transdermal donepezil on the treatment of Alzheimer's disease[J]. Neuropsychiatr Dis Treat, 2012, 8: 361-368. doi: 10.2147/NDT.S16089.
[12] 周智林,梁丽贞,严永兴. 多奈哌齐对阿尔茨海默病患者甲状腺功能的影响研究[J]. 中国老年保健医学, 2006, 4(2): 23-24.
[13] 高旭红,赵海花,赖红,等. 多奈哌齐对AD大鼠海马结构神经元的保护作用[J].中国组织化学与细胞化学杂志, 2012, 21(1): 33-36.
[14] De Souza E B, Whitehouse P J, Kuhar M J, et al. Reciprocal changes in corticotrophin-releasing factor(CRF)-like immunoreactivity and CRH receptors in cerebral cortex of Alzheimer's disease[J]. Nature, 1986, 319(6054): 593-595.
[15] Carroll J C, Iba M, Bangasser D A, et al. Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy[J]. J Neurosci, 2011, 31(40): 14436-14449.
[1] LIU Xin， YANG Lejin， FAN Shujuan, JIANG Hong, PAN Fang
. Aerobic exercise protects rats with chronic unpredictable mild stress against acute stress [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(02): 88-91.
[2] JIANG Hong,ZHANG Qian,SUN Yu,PAN Fang. Correlation between state-trait anxiety, personality, coping style and the cortisol level in medical freshmen [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(9): 866-868.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd